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Abstract
Background—Research suggests individuals with diabetes are twice as likely as those without
diabetes to be clinically depressed. Still unknown is the relationship between diabetes and
depression in socioeconomically disadvantaged populations.
Purpose—We examined the relationship between diabetes and depressive symptoms in a large,
racially diverse, low-income cohort in the southeastern United States.
Methods—69,068 adults were recruited from community health centers in the twelve
southeastern states in the U.S. A fully adjusted polytomous logistic regression model tested the
relationship between demographics, lifestyle behaviors, antidepressant use, body mass index,
diabetes diagnosis, diabetes duration, diabetes medication compliance, and depressive symptoms
using the Centers for Epidemiological Studies Depression scale.
Results—Diabetes was present in 21.7% of sample. While a diabetes diagnosis was associated
with having severe depressive symptoms (AOR: 1.24, 95% CI: 1.14-1.34), demographics, lifestyle
behaviors, antidepressant use, body mass index were more strongly associated with severe
depressive symptoms than a diabetes diagnosis.
Conclusions—Having diabetes was associated with the presence and severity of depressive
symptoms in a large, low-income sample of racially diverse adults. However, the relationship
between diabetes and depressive symptoms was weaker than other studies with higher
socioeconomic groups.
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According to the World Health Organization, depression continues to be highly prevalent,
accounts for more disability worldwide than any other psychiatric disorder, and is projected
to be the second most prevalent medical condition by 2020.(1) Prospective, retrospective
and meta-analytic studies highlight significantly higher rates of depression among persons
with diabetes relative to the general population.(2,3) The most commonly cited statistic,
based on a meta analysis of 42 studies, is that diabetes doubles the risk of depression.(4)
Depression is an independent risk factor for poor health outcomes and increased mortality,
even after controlling for diabetes status.(5,6) In a prospective cohort study, depression was
associated with follow-up mortality, even after accounting for a history of diabetes.(6)
Individuals with diabetes and co-morbid depression have been shown to have poor
adherence to diabetes medications (7), poor adherence to dietary recommendations (7), poor
glycemic control (8), more diabetes-related complications (9), and a higher risk of mortality
than individuals with diabetes who are not depressed.(10,11) In a large cohort study of
insurance beneficiaries with diabetes, co-morbid depression was associated with a 36-38%
increased risk of all-cause mortality compared to persons with diabetes only.(11) In a
separate cohort study, co-morbid depression was associated with a 1.3-fold increased risk of
all-cause mortality.(12) The human toll of diabetes and co-morbid depression translates into
a 50% increase in health care costs compared to the cost of treating diabetes alone.(12)
Integrating diabetes and depression treatment can improve health outcomes in individuals
with both conditions (13), thereby reducing their human and economic burden.
Race/ethnicity and socioeconomic status (SES) may be risk factors for co-morbid depression
among persons with diabetes. Racial and ethnic disparities in diabetes prevalence and
complications are well documented in the literature.(14,15) However, less is known about
disparities in the prevalence of co-morbid depression. In contrast to studies with
predominantly White patients that find a positive association between diabetes and
depression, one study showed no association in a sample of African American patients.(16)
Other work has shown similar rates of depressive symptoms in African Americans and
Whites with diabetes (17), including an association between depression and poor glycemic
control in both groups.(18) Furthermore, SES has been related to both greater levels of
depressive symptoms (19), and a greater risk of developing type 2 diabetes.(20) However,
the relationship between SES, depression, and diabetes may not only exist at the lowest
social strata; there is some evidence to suggest a graded relationship along the entire SES
continuum.(21)
The objective of this study was to examine the relationship between diabetes and depressive
symptoms in a large sample of racially diverse, low-income, older adults participating in the
Southern Community Cohort Study.(22) We have previously reported that antidepressant
medication use among persons with diabetes was inversely related to SES, but lower among
African American than White Southern Community Cohort Study participants.(23) Herein
we characterize the association between levels of depressive symptoms among individuals
with vs. without diabetes after controlling for SES, lifestyle and other variables.
Methods
Recruitment of Participants
The Southern Community Cohort Study is a prospective cohort study designed to identify
causes of health disparities between African Americans and Whites in the incidence and
mortality rates of several cancers and other chronic diseases.(22) Participants were enrolled
primarily in-person at public community health centers located in twelve southeastern states
in the U.S. Trained study interviewers enrolled participants by approaching people entering
the clinic (patients, persons accompanying patients, etc.) and screening them for eligibility
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and interest in study participation. Participants were required to be between the ages of 40
and 79, English speaking, and not be treated for cancer (excluding non-melanoma skin
cancer) within the past year. After providing informed consent, interviewers collected
baseline data using a computer assisted personal interview. The baseline interview contained
a battery of questions, including those which ascertained participants’ demographics and
lifestyle behaviors, depressive symptoms, and medical history.
The study was approved by the institutional review boards at Vanderbilt University and
Meharry Medical College in Nashville, Tennessee, U.S.
Measures
Demographics—Demographics included age, gender, race/ethnicity, education,
employment status, annual household income, marital status, health insurance status.
Lifestyle behaviors—Lifestyle behaviors included self-reported cigarette smoking status
and alcohol consumption.
Antidepressant use—Participants were asked if they were taking any antidepressant
medication, and then asked for the name(s) of all medications of this type being taken.
Body mass index—Body mass index (BMI = kg/m2) was computed from self-reported
height and weight. A categorical variable was created to represent underweight (BMI <
18.5), normal weight (18.5 ≤ BMI <25), overweight (25 ≤ BMI ≤30), and obese (30 <BMI).
Diabetes diagnosis—Participants with diabetes were identified using the question, “Has
a doctor ever told you that you have diabetes?” Participants who answered “yes” to this
question were selected as having a diabetes diagnosis. In two validation studies, one
involving a review of medical records and the other involving an assessment of HbA1c
percentages, the self-reported diagnoses of diabetes were confirmed for 96% of those
reporting diabetes.(24)
Diabetes duration—Participants with a diabetes diagnosis were asked how many years
they have had diabetes, and whether they are taking diabetes medications.
Diabetes medication compliance—Those taking diabetes medications were also asked,
“During the past three months, how often did you take your diabetes medication as
instructed by your doctor?” Response options were in 5-point Likert format, 1 = all the time,
2 = most of the time, 3 = sometimes, 4 = rarely, 5 = never. In our analysis, responses were
recoded to 1 = excellent compliance, 2 = good compliance, ≥3 = poor compliance.
Depressive symptoms—Depressive symptoms were assessed using the 10-item version
of the Centers for Epidemiological Studies Depression (CES-D) scale, a valid and reliable
measure of the presence and severity of depressive symptoms.(25) Cutoffs of 10, 15, and 20
are used to define mild, moderate, and severe levels of depressive symptoms.(25)
Study Subject Exclusions
The initial data set consisted of 69,068 Southern Community Cohort Study participants.
Individuals who were age < 40 years (n = 2), or had missing values for education (n = 45),
annual household income (n = 736), marital status (n = 8), health insurance status (n = 336),
cigarette smoking status (n = 100), alcohol consumption (n = 310), did not answer the
question about antidepressant use (n = 37), BMI (n = 1575), did not answer the question
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about having diabetes or hypertension (n = 53), depressive symptoms score (n = 99), were
excluded, resulting in 65,767 participants selected for analyses.
Statistical Analyses
Descriptive statistics were performed to describe the distribution of each variable across
participants reporting none, mild, moderate, and severe depressive symptoms. Means and
SDs were computed for age, and frequencies and proportions were computed for the
remaining variables. A bivariate unadjusted ANOVA model was performed to test the mean
age difference across the levels of depressive symptoms. Bivariate chi-square tests examined
differences on demographics (gender, race/ethnicity, education, employment status, annual
household income, marital status, and health insurance status), lifestyle behaviors (cigarette
smoking status and alcohol consumption), antidepressant use, BMI, diabetes diagnosis,
diabetes duration, and diabetes medication compliance across the levels of depressive
symptoms. A fully adjusted polytomous logistic regression model was performed to
examine the associations (adjusted odds ratios and corresponding 95% confidence intervals)
between levels of depressive symptoms and demographics (age, gender, race/ethnicity,
education, employment status, annual household income, marital status, and health
insurance status), lifestyle behaviors (cigarette smoking status and alcohol consumption),
antidepressant use, BMI, and diabetes diagnosis. The Mantel-Haenszel test was used to
examine the linear trend of the odds ratios across levels of depressive symptoms within each
variable. Statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary,
NC). All statistical tests were based on two-tailed probability distributions.
Results
The presence and severity of depressive symptoms by participant characteristics are
presented in Table 1. Reflecting the low socioeconomic groups community health centers
typically serve, participants in the Southern Community Cohort Study tended to have low
annual incomes (61% had below $15,000), less education (32% had less than a high school
degree), and were currently unemployed (63%). The median age at enrollment was 52 years,
60% were female and 71% were African American. Overall 42% had CES-D scores
indicative of mild (23%), moderate (12%) or severe (7%) depressive symptoms, but the
percentages varied significantly by demographics, lifestyle behaviors, antidepressant use,
BMI, and diabetes factors (diagnosis, duration, compliance). For each factor, the differences
across categories were highly significant, (p< .01) because of the large sample sizes
involved. Severe depressive symptoms were nearly twice as common in females as in males;
in Whites as in African Americans; in those with incomes less than $15,000 than in those
with incomes more than $25,000; in those with less than a high school education as in those
with a college education; and in those who were unemployed as in those who were
employed. Smaller yet still significant differences were also seen with other indicators, with
a higher prevalence of depressive symptoms among current smokers and those who were
underweight or obese compared to those who were normal or overweight.
Among participants with diabetes, 8.3% reported severe depressive symptoms and 12.8%
reported moderate depressive symptoms, rates modestly higher than those without diabetes
(6.9% and 11.7%). As shown in Table 1, rates of severe depressive symptoms tended to
decline slightly with diabetes duration, and were considerably lower among participants who
reported excellent medication compliance vs. poor medication compliance.
Table 2 illustrates a fully adjusted polytomous logistic regression model examining the
association between depressive symptoms and demographics, lifestyle behaviors,
antidepressant use, BMI, and diabetes diagnosis. Compared to participants between the ages
of 40 and 49 years, the odds of having mild, moderate, and severe depressive symptoms
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decreased markedly with advancing age. The bivariate associations suggested by the Chi-
square tests in Table 1 generally remained intact after adjusting for covariates in the
regression model. In particular, the odds of depressive symptoms were significantly elevated
among females, Whites, those with lower incomes and less education, the unemployed, as
well as the uninsured, smokers and those who were underweight.
As shown in Table 2, participants with diabetes were more likely than those without diabetes
to report mild (AOR = 1.15; CI = 1.09-1.21), moderate (AOR = 1.17; 1.10-1.25), and severe
depressive symptoms (AOR = 1.24; 1.14-1.34). However, based on an examination of the
odds ratios in Table 2, demographics, lifestyle behaviors, antidepressant use, and BMI were
more strongly associated with depressive symptoms than having a diabetes diagnosis.
Participants with diabetes who reported “poor” medication compliance were more likely
than those who reported excellent medication compliance to have mild (AOR = 1.60;
1.29-1.98), moderate (AOR = 2.03; 1.56-2.64), or severe depressive symptoms (AOR =
2.74; 2.04-3.70). Diabetes duration was unrelated to the presence and severity of depressive
symptoms. In addition, there were no significant interactions between race/ethnicity and
diabetes status, and between gender and diabetes status.
Discussion
We investigated the relationship between diabetes and co-morbid depression in a large, low-
income cohort of racially diverse older adults at community health centers in the
southeastern U.S. Our results deepen our understanding of the complex interplay between
depression and diabetes, and challenge the conventionally accepted view that diabetes
substantially increases the risk of depression. Consistent with other studies, a diabetes
diagnosis was significantly associated with the presence and severity of depressive
symptoms after adjustment for relevant demographics, lifestyle behaviors, antidepressant
use, and BMI.(2,3) However, the relationship between diabetes status and depressive
symptoms in our study was much weaker than has been previously reported.(4) Most studies
report that a diabetes diagnosis doubles the risk of depression.(4) We found that
demographics (age, gender, race/ethnicity, education, employment status, annual household
income, marital status, and health insurance status), lifestyle behaviors (cigarette smoking
status and alcohol consumption), antidepressant use, and BMI were more strongly associated
with the presence and severity of depressive symptoms than a diabetes diagnosis. Factors
unmeasured in this study, such as functional impairment (26), may be an even stronger
predictor of depressive symptoms than having diabetes and/or having the other risk factors
identified here.
Our results are in accord with a recently published study in which patients with diabetes had
little or no increased risk of a new diagnosis of depression relative to patients without
diabetes after controlling for the number of outpatient visits.(27) In our study, we found a
weak relationship between a diabetes diagnosis and depressive symptoms among a cohort
recruited from visitors to community health centers. There are several plausible explanations
for why the relationship between diabetes and depression in the Southern Community
Cohort Study may not be as strong as in other studies. Diabetes and co-morbid depression
studies tend to employ different methods of recruiting subjects, with nearly all other studies
including the use of smaller, racially/ethnically homogenous samples, generally from private
clinics, hospitals, or an unspecified setting.(4) There are also variations in sources of data,
severity indicators for depression and diabetes, and the ability to control for lifestyle
behaviors and other factors which may influence both diabetes and depression.(27,28)
Overall, 42% of the total Southern Community Cohort Study sample reported mild,
moderate, or severe depressive symptoms. In a meta-analysis of 42 studies, only a handful of
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studies were performed in community settings and used a version of the CES-D to assess
depression.(4) In those studies, 22-31% participants with diabetes and 13-24% participants
without diabetes reported severe depressive symptoms.(29,30) In our low SES sample of
older adults, the prevalence of severe depressive symptoms assessed by CES-D scores was
modestly higher for those with diabetes (~8.3%) than those without diabetes (~6.9%). While
it appears that the participants in our study regardless of diabetes diagnosis were less
severely depressed than comparable studies reported in meta-analytic work, and restricted
range or low levels of depression might be an alternative explanation for the findings, we
caution readers about making one-to-one comparisons. Diabetes and co-morbid depression
studies vary widely in their sampling approaches, sample characteristics (e.g., type of
diabetes; racial/ethnic heterogeneity, SES variability, pediatric vs. adult), measures used to
assess depression (e.g., there are twelve short forms of the CES-D (31)), and cutoff scores
used to classify depression cases.(2,4) Furthermore, studies on community-dwelling older
adults with diabetes published since the meta-analysis of 42 studies was performed have also
documented lower rates of depression. For example, Bell et al. reported a rate of 15.8%
(CES-D of ≥ 9) in an ethnically diverse, lower educated sample.(32) Black et al. reported a
rate of 6.6% (CES-D of ≥16) in a Mexican American, lower educated sample. Thus, the
extent to which our findings differ from others as a function of restricted range and low
depression levels is unclear. Additional research is needed with comparable samples, same
versions of the CES-D and cutoff scores used to classify depression in order to both
determine this and understand reasons for lower or higher rates of depression reported across
studies.
While there is a substantial body of research on diabetes and co-morbid depression, our
findings help fill significant gaps in the literature about the association between diabetes and
depression among socioeconomically disadvantaged populations.(16,17,32) It was unknown,
prior to this study, whether a diabetes diagnosis might be more predictive of having
depression in socioeconomically disadvantaged, predominately African American
populations. Participants in the Southern Community Cohort Study had low annual incomes,
less education, and were predominately unemployed and African American. In models
predicting depression status and severity, these socioeconomic factors were strongly related
to the presence and severity of depressive symptoms. This is consistent with other
observations in ethnic minority samples with and without diabetes.(33,34) However, our
findings take it one step further, suggesting low SES is a stronger predictor of depression
than a diabetes diagnosis.
There are several study limitations to acknowledge. First, diabetes diagnosis was self-
reported and not based on chart review or biological testing. However, in a separate
validation study, 124 medical records of Southern Community Cohort Study participants
reporting a prior diagnosis of diabetes were reviewed and 96% of the self-reports were
validated based on criteria including the International Statistical Classification of Disease
and Related Health Problems (ICD-9) codes, physician notes or prescriptions, and/or HbA1c
or blood glucose measurements from the medical records.(24) Thus, a lack of validity of
self-reported diabetes in this study is an unlikely explanation for the findings. A more
plausible limitation is the underreporting of diabetes either because participants did not
know their status or they were unwilling to report it, so that some participants we classified
as not having diabetes may have actually had the disease. Such an effect, which would tend
to dilute differences between participants with diabetes and those without diabetes and could
lower the odds ratios, is common to other studies as well.
Second, we assessed diabetes medication compliance with a single, self-report item created
for the study rather than a validated self-report measure or more objective measures of
medication adherence such as refill adherence or electronic monitoring devices. While it is
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possible participants under-reported non-adherence in response to this question, recent
studies suggest brief self-report measures and single item measures can be viable and
accurate measures of medication adherence.(35,36)
Third, while both the full-length 20-item CES-D and 10-item CES-D have been validated in
various populations, including multi-ethnic groups with diabetes (37,38), the full-length
version is not psychometrically equivalent across race/ethnicity or immigrant generations
and has demonstrated false positive rates in some low-income settings.(39,40) Less is
known about the psychometric equivalence of the 10-item CES-D across socioeconomic
groups.
Fourth, the prevalence of depression varies systematically as a function of the method used
to identify depression cases and the study design. Rates of depression have been shown to be
two to three times higher in diabetes studies using self-report measures versus diagnostic
interviews (4), as the two approaches identify somewhat different but overlapping samples
of depressed individuals. Self-report measures identify most cases of major depressive
disorder, whereas diagnostic interviews identify major depressive disorder but exclude other
clinically relevant presentations. In this study, depressive symptoms were self-reported. Had
we used diagnostic interviews to identify depression, the magnitude of the relationship
between diabetes status and depressive symptoms in this study might have differed.
Finally, because this is a cross-sectional study, inferences regarding causal and temporal
relationships cannot be made. Other limitations include the inability to distinguish between
type 1 and type 2 diabetes in the Southern Community Cohort Study questionnaire, although
the large majority reported adult-onset diabetes, and the inability to generalize to younger,
more educated or more affluent populations. Our goal was to compose a sample of
individuals arriving at community health centers (patients, persons accompanying patients,
etc.) in twelve U.S. states, age 40-79 years, English speaking, who had not been treated for
cancer (excluding non-melanoma skin cancer) within the past year. For practical reasons, we
were unable to randomly select individuals arriving at community health centers, but we
have no reason to suspect that participants who enrolled in the Southern Community Cohort
Study differed substantially from the overall clinic population. Indeed, the low education
and income status of the Southern Community Cohort Study participants coincides with the
low SES status of the large majority of persons attending community health centers, and the
male to female ratio of the cohort is similar to the male to female ratio of clinic patients.
Nevertheless, we cannot rule out that some systematic differences of those volunteering to
enter the Southern Community Cohort Study might have influenced the associations of
interest.
Despite these limitations, our findings extend the spectrum of what is known about diabetes
and co-morbid depression, as prior studies have been limited by higher SES and less racially
diverse samples. Our study reports a significant association between co-morbid depression
and a diabetes diagnosis in a large, low-income, predominantly African American sample,
but with at a lower magnitude than seen elsewhere. While our findings suggest a weaker
depression-diabetes association than previously reported, we cannot infer depression has any
less of an impact on the health and well-being of these groups. In this study, we also found
participants with diabetes and depressive symptoms had poor diabetes medication
compliance than those without depressive symptoms, suggesting that the presence of
depression at any degree might still be associated with poor diabetes self-care activities.
The mechanisms underlying the weaker association between diabetes and co-morbid
depression cannot be drawn from the current results. Prospective studies with similar
samples are needed to explore the causes and consequences of co-morbid depression on a
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range of outcomes relevant to diabetes care in low SES groups (e.g., glycemic control,
utilization of health care services, mortality). Extended follow up of the Southern
Community Cohort Study participants offers great potential to provide a rich prospective
dataset that will help in understanding societal and physiologic mechanisms underlying the
causes and consequences of co-morbid depression in diabetes; and, most importantly, allow
for identifying causal relationships in a lower SES population.
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Table 1
Demographics, lifestyle behaviors, body mass index, anti-depressant use, and diabetes diagnosis of the
Southern Community Cohort Study population; diabetes duration and medication complication presented on












 Age, Mean (SD) 52.4 (9.3) 50.7 (8.3) 50.1 (7.6) 49.6 (6.9)
 Gender
   Male 15924 (61.0) 6268 (24.0) 2707 (10.4) 1206 (4.6)
   Female 21939 (55.3) 9054 (22.8) 5125 (12.9) 3544 (8.9)
 Race/ethnicity
   White 9029 (53.6) 3609 (21.4) 2338 (13.9) 1865 (11.1)
   African-American 27612 (59.3) 11158 (24.0) 5179 (11.1) 2615 (5.6)
   Others/mixed race 1222 (51.7) 555 (23.5) 315 (13.3) 270 (11.4)
 Education
   Less than high school 10357 (49.5) 5634 (26.9) 3083 (14.7) 1857 (8.9)
   High school 15286 (57.8) 6255 (23.6) 3099 (11.7) 1825 (6.9)
   Some college or junior college 7818 (62.5) 2593 (20.7) 1258 (10.1) 834 (6.7)
   College higher 4402 (75.0) 840 (14.3) 392 (6.7) 234 (4.0)
 Employment status
   No 21353 (51.8) 10265 (24.9) 5795 (14.1) 3815 (9.3)
   Yes 16238 (67.9) 4875 (20.4) 1931 (8.1) 873 (3.7)
 Annual household income
   < $15,000 20395 (50.9) 10426 (26.0) 5619 (14.0) 3598 (9.0)
   $15,000 to <$25,000 9167 (62.7) 3261 (22.3) 1465 (10.0) 736 (5.0)
   $25,000 to <$50,000 5674 (71.9) 1292 (16.4) 589 (7.5) 340 (4.3)
   $50,000 + 2627 (82.0) 343 (10.7) 159 (5.0) 76 (2.4)
 Marital status
   Married/cohabitate 13305 (64.2) 4189 (20.2) 2055 (9.9) 1174 (5.7)
   Divorced 12294 (53.5) 5530 (24.1) 3022 (13.2) 2132 (9.3)
   Widowed 3875 (59.5) 1488 (22.9) 703 (10.8) 443 (6.8)
   Single 8389 (53.9) 4115 (26.5) 2052 (13.2) 1001 (6.4)
 Health insurance status
   No 15499 (54.1) 7102 (24.8) 3670 (12.8) 2378 (8.3)
   Yes 22364 (60.3) 8220 (22.2) 4162 (11.2) 2372 (6.4)
LIFESTYLE BEHAVIORS
 Cigarette smoking status
   Never 14198 (60.6) 4901 (21.6) 2291 (10.1) 1292 (5.7)
   Former smoker 8651 (62.8) 2854 (20.7) 1432 (10.4) 835 (6.1)
   Current smoker 15014 (51.2) 7567 (25.8) 4109 (14.0) 2623 (9.0)
 Alcohol consumption
























   Non-drinker 18421 (59.1) 6970 (22.4) 3505 (11.2) 2284 (7.3)
   < 1/day 11640 (57.9) 4543 (22.6) 2441 (12.1) 1493 (7.4)
   ≥ 1/day and < 4/day 4310 (56.9) 1924 (25.4) 882 (11.6) 465 (6.1)
   4 or more/day 3492 (50.7) 1885 (27.4) 1004 (14.6) 508 (7.4)
BODY MASS INDEX (kg/m2)
   Normal weight: 18.5 ≤ to < 25 9205 (57.2) 3929 (24.4) 1872 (11.6) 1084 (6.7)
   Under weight: < 18.5 441 (50.3) 218 (24.9) 126 (14.4) 91 (10.4)
   Overweight: 25 ≤ to ≤ 30 11456 (60.0) 4326 (22.7) 2113 (11.1) 1198 (6.3)
   Obese: > 30 16761 (56.4) 6849 (23.1) 3721 (12.5) 2377 (8.0)
ANTI-DEPRESSANT USE
   No 33736 (63.2) 12034 (22.6) 5138 (9.6) 2434 (4.6)
   Yes 4127 (33.2) 3288 (26.5) 2694 (21.7) 2316 (18.6)
DIABETES DIAGNOSIS
   No 30050 (58.4) 11870 (23.1) 6001 (11.7) 3567 (6.9)
   Yes 7813 (54.7) 3452 (24.2) 1831 (12.8) 1183 (8.3)
DIABETES DURATION *
   year or less 1335 (54.2) 602 (24.4) 309 (12.5) 218 (8.9)
   2-3 years 1231 (55.2) 503 (22.6) 309 (13.9) 188 (8.4)
   4-10 years 2588 (55.1) 1124 (23.9) 591 (12.6) 395 (8.4)
   more than 10 years 2565 (54.4) 1179 (25.0) 602 (12.8) 369 (7.8)
DIABETES MEDICATION COMPLIANCE *
   Excellent 5787 (57.2) 2381 (23.6) 1213 (12.0) 730 (7.2)
   Good 705 (48.1) 390 (26.6) 219 (14.9) 152 (10.4)
   Poor 233 (42.5) 150 (27.4) 92 (16.8) 73 (13.3)
*
Only for participants with diabetes.
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Table 2
Associations between depressive symptoms, demographics, lifestyle behaviors, anti-depressant use, body mass
index, and diabetes diagnosis in the Southern Community Cohort Study population
Variables
Depressive Symptoms Trend










   40-49 1.00 1.00 1.00
   50-59 0.94 (0.90 0.98) 0.91 (0.86 0.96) 0.86 (0.80 0.92) <0.001
   60-69 0.60 (0.56 0.64) 0.47 (0.43 0.52) 0.32 (0.28 0.36) <0.001
   70 + 0.48 (0.43 0.54) 0.30 (0.25 0.36) 0.15 (0.11 0.20) <0.001
 Gender
   Male 1.00 1.00 1.00
   Female 1.15 (1.10 1.20) 1.49 (1.41 1.58) 2.15 (1.99 2.33) <0.001
 Race/ethnicity
   White 1.00 1.00 1.00
   African-American 0.99 (0.94 1.03) 0.79 (0.74 0.84) 0.59 (0.55 0.63) <0.001
   Others 1.18 (1.06 1.32) 1.09 (0.94 1.25) 1.22 (1.04 1.42) 0.37
 Education
   less than high school 1.00 1.00 1.00
   High school 0.77 (0.73 0.80) 0.69 (0.65 0.73) 0.66 (0.61 0.71) <0.001
   Some college or junior college 0.64 (0.61 0.68) 0.54 (0.50 0.58) 0.55 (0.50 0.61) <0.001
   College higher 0.48 (0.44 0.52) 0.40 (0.35 0.45) 0.38 (0.33 0.45) <0.001
 Employment status
   No 1.00 1.00 1.00
   Yes 0.78 (0.74 0.81) 0.59 (0.56 0.63) 0.45 (0.41 0.49) <0.001
 Annual household income
   < $15,000 1.00 1.00 1.00
   $15,000 to <$25,000 0.84 (0.80 0.88) 0.78 (0.73 0.83) 0.65 (0.60 0.71) <0.001
   $25,000 to <$50,000 0.63 (0.59 0.68) 0.63 (0.57 0.69) 0.63 (0.56 0.72) <0.001
   $50,000 + 0.44 (0.39 0.50) 0.45 (0.38 0.54) 0.38 (0.30 0.49) <0.001
 Marital status
   Married/cohabitate 1.00 1.00 1.00
   Divorced 1.18 (1.12 1.24) 1.27 (1.19 1.36) 1.53 (1.41 1.66) <0.001
   Widowed 1.13 (1.05 1.22) 1.09 (0.99 1.21) 1.24 (1.10 1.41) **
   Single 1.20 (1.13 1.26) 1.25 (1.16 1.35) 1.17 (1.06 1.29) <0.001
 Health insurance status
   No 1.00 1.00 1.00
   Yes 0.93 (0.90 0.97) 0.88 (0.83 0.93) 0.72 (0.67 0.77) <0.001
LIFESTYLE BEHAVIORS
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Variables
Depressive Symptoms Trend








 Cigarette smoking status
   Never 1.00 1.00 1.00
   Former smoker 0.93 (0.88 0.98) 0.98 (0.91 1.05) 0.99 (0.90 1.09) **
   Current smoker 1.15 (1.09 1.20) 1.27 (1.19 1.36) 1.43 (1.32 1.55) <0.001
 Alcohol consumption
   Non-drinker 1.00 1.00 1.00
   < 1/day 1.05 (1.00 1.10) 1.17 (1.10 1.24) 1.11 (1.03 1.20) 0.01
   ≥ 1/day and < 4/day 1.13 (1.06 1.21) 1.19 (1.08 1.30) 1.12 (1.00 1.26) 0.84
   4 or more/day 1.26 (1.17 1.35) 1.57 (1.43 1.72) 1.47 (1.31 1.66) <0.001
ANTI-DEPRESSANT USE
   No 1.00 1.00 1.00
   Yes 2.18 (2.07 2.30) 3.74 (3.51 3.98) 5.75 (5.35 6.19) 0.00
BODY MASS INDEX (kg/m2)
   Normal weight:18.5 ≤ to < 25 1.00 1.00 1.00
   Under weight: < 18.5 1.04 (0.88 1.23) 1.17 (0.95 1.45) 1.38 (1.08 1.78) **
   Overweight: 25 ≤ to ≤ 30 0.98 (0.93 1.03) 1.01 (0.94 1.09) 0.98 (0.89 1.07) **
   Obese: ≥ 30 1.03 (0.98 1.09) 1.14 (1.06 1.22) 1.13 (1.04 1.23) **
DIABETES DIAGNOSIS
   No 1.00 1.00 1.00
   Yes 1.15 (1.09 1.21) 1.17 (1.10 1.25) 1.24 (1.14 1.34) <0.001
*
Mantel-Haenszel linear trend test
**
Cannot conduct trend test.
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